Bergen, Norway 22 April 2022
The Annual General Meeting ("AGM") of Lifecare AS will be held on 6 May 2022 at10:00 CET. Notice of the AGM is enclosed to this announcement.
The meeting will be conducted as a combined physical and digital meeting.Shareholders who wish to participate and vote at the General Meeting must beregistered with a user profile in the meeting portal Orgbrain (www.orgbrain.no).It will be possible to attend the meeting in person or digitally throughOrgbrain. Further information about participation and registration appears fromthe notice.
To save the environment and reduce costs incurred sending the notification bypost to the shareholders, please see attached a manual (in Norwegian) on how toreceive notices and information electronically instead of by post.
This is LifecareLifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people with diabetes. The company's patented technology also has thepotential for use in various biomarkers. Lifecare AS is listed on EuronextGrowth Oslo (LIFE).
Further informationJoacim Holter, CEO, Lifecare AS, firstname.lastname@example.org, +47 40 05 90 40
This information is subject to the disclosure requirements pursuant to Section5-12 the Norwegian Securities Trading Act. This stock exchange announcement waspublished by Kine Hereid, Investor Relations at Lifecare AS, on 22 April 2022 at10:45 CET.